<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903003</url>
  </required_header>
  <id_info>
    <org_study_id>KIA 2018/506</org_study_id>
    <nct_id>NCT03903003</nct_id>
  </id_info>
  <brief_title>Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.</brief_title>
  <official_title>In the Study; Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli Derince Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli Derince Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its
      Effects on Newborn.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who will undergo caesarean section under general anesthesia will be included in the
      study.

      In the study; preoxygenation is applied to the caesarean sections under general anesthesia in
      two ways. Group1 includes preoxygenation masked patients.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 8, 2018</start_date>
  <completion_date type="Anticipated">December 8, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>durations of stay</measure>
    <time_frame>24 hours</time_frame>
    <description>compare the durations of stay in the intensive care unit and in hospital</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cesarean Delivery Affecting Newborn</condition>
  <arm_group>
    <arm_group_label>preoxygenation mask applied to the cesarean</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In order to protect the mother from hypoxia, preoxygenation is performed with face mask before induction of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high flow nasal oxygenation applied to the ceserian</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In order to protect the mother from hypoxia, preoxygenation is performed with high flow nasal oxygenation mask before induction of anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>high flow nasal oxygen device (POİNT)</intervention_name>
    <description>With POINT device (peri-operative insufflatory nasal therapy); patients are heated at higher flow and applied to humidified oxygen.</description>
    <arm_group_label>high flow nasal oxygenation applied to the ceserian</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Face mask</intervention_name>
    <description>In order to protect the mother from hypoxia, preoxygenation is performed with face mask before induction of anesthesia.</description>
    <arm_group_label>preoxygenation mask applied to the cesarean</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 18 years old;

          -  Patients undergoing elective ceserian operation

        Exclusion Criteria:

          -  Patients who refuse to participate in the study;

          -  Patients under emergency conditions.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehmet Yılmaz</last_name>
    <role>Study Director</role>
    <affiliation>HEALTH AND SCİENCE UNIVERSITY MEDICAL SCHOOL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kocaeli Derince Education and Research Hospital</name>
      <address>
        <city>Kocaeli</city>
        <zip>41400</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli Derince Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>EMİNE YURT</investigator_full_name>
    <investigator_title>clinical researcher</investigator_title>
  </responsible_party>
  <keyword>high flow nasal oxygen (POİNT)</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

